Takeda logo

SEC Filings | Takeda Investor Relations

Form 20-F


We will provide a hard copy of our latest Annual Report on Form 20-F, which includes the most recent complete audited financial statements, free of charge to any securityholder upon request. Securityholders should e-mail our Investor Relations team at [email protected] to request a hard copy.

Securities Reports


FY2023 – April 1, 2023 – March 31, 2024

147th Fiscal Year

FY2022 – April 1, 2022 – March 31, 2023

146th Fiscal Year

FY2021 - April 1, 2021 to March 31, 2022

145th Fiscal Year

FY2020 - April 1, 2020 to March 31, 2021

144nd Fiscal Year

FY2019 - April 1, 2019 to March 31, 2020

143rd Fiscal Year

FY2018 - April 1, 2018 to March 31, 2019

142nd Fiscal Year

*These reports are translations of the Securities Reports submitted to the Japanese FSA (Financial Services Agency) The English version of the Annual Securities Report/Quarterly Securities Report is provided as a reference material to assist foreign investors in understanding the Securities Report, which was filed with Japanese FSA (Financial Services Agency). We do not provide assurance about the accuracy, validity, or coverage of the English translation of this document, and if the description and explanation of this document differs from those of the Japanese Annual Securities Report/Quarterly Securities Report which was filed, the Securities Report in Japanese shall prevail.

Consolidated Financial Statements Under IFRSs and Independent Auditor's Report

*These reports are excerpts from translation of the Japanese Consolidated Financial Statements submitted to FSA (Financial Services Agency) with Independent Auditor’s report

Shire SEC documents

View Shire SEC documents (EDGAR Search Results)Go to https://www.sec.gov/edgar/browse/?CIK=936402

Sign up for our investors newsletter

Stay up to date on financial results, corporate milestones and learn how we're delivering on our commitment to patients, our people and the planet

Sign up